GR3034772T3 - Growth differentiation factor-12 - Google Patents
Growth differentiation factor-12Info
- Publication number
- GR3034772T3 GR3034772T3 GR20000402461T GR20000402461T GR3034772T3 GR 3034772 T3 GR3034772 T3 GR 3034772T3 GR 20000402461 T GR20000402461 T GR 20000402461T GR 20000402461 T GR20000402461 T GR 20000402461T GR 3034772 T3 GR3034772 T3 GR 3034772T3
- Authority
- GR
- Greece
- Prior art keywords
- pct
- differentiation factor
- growth differentiation
- gdf
- sec
- Prior art date
Links
- 102000000429 Factor XII Human genes 0.000 title abstract 2
- 108010080865 Factor XII Proteins 0.000 title abstract 2
- 230000004069 differentiation Effects 0.000 title abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/274,215 US5831054A (en) | 1994-07-13 | 1994-07-13 | Polynucleotide encoding growth differentiation factor-12 |
| US31137094A | 1994-09-26 | 1994-09-26 | |
| PCT/US1995/008745 WO1996002559A1 (en) | 1994-07-13 | 1995-07-12 | Growth differentiation factor-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3034772T3 true GR3034772T3 (en) | 2001-02-28 |
Family
ID=26956672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20000402461T GR3034772T3 (en) | 1994-07-13 | 2000-11-07 | Growth differentiation factor-12 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5929213A (el) |
| EP (1) | EP0770089B1 (el) |
| JP (1) | JPH10503362A (el) |
| AT (1) | ATE196147T1 (el) |
| CA (1) | CA2195246A1 (el) |
| DE (1) | DE69518760T2 (el) |
| DK (1) | DK0770089T3 (el) |
| ES (1) | ES2151607T3 (el) |
| GR (1) | GR3034772T3 (el) |
| PT (1) | PT770089E (el) |
| WO (1) | WO1996002559A1 (el) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846770A (en) * | 1994-11-22 | 1998-12-08 | Genetics Institute, Inc. | DNA molecules encoding human chordin |
| US5965403A (en) | 1996-09-18 | 1999-10-12 | Genetics Institute, Inc. | Nucleic acids encoding bone morphogenic protein-16 (BMP-16) |
| US20020052026A1 (en) | 1997-10-08 | 2002-05-02 | Steven M. Vicik | Methods of refolding proteins |
| US6027917A (en) | 1997-12-10 | 2000-02-22 | Genetics Institute, Inc. | Bone morphogenetic protein (BMP)-17 and BMP-18 compositions |
| US6727224B1 (en) | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
| NZ519546A (en) * | 1999-12-15 | 2005-07-29 | Res Dev Foundation | Betaglycan as an inhibin receptor and uses thereof |
| TWI267378B (en) | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
| CN1878565B (zh) | 2003-09-12 | 2011-01-12 | 惠氏公司 | 用于递送成骨蛋白的注射型磷酸钙固体小棒剂和糊剂 |
| AU2005247871A1 (en) | 2004-04-27 | 2005-12-08 | Research Development Foundation | Antagonism of TGF-beta superfamily receptor signaling |
| US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
| US8147860B2 (en) | 2005-12-06 | 2012-04-03 | Etex Corporation | Porous calcium phosphate bone material |
| CA2641860C (en) | 2006-02-09 | 2015-07-14 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating bone |
| US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
| JP5484047B2 (ja) | 2006-06-30 | 2014-05-07 | バイオミメティック セラピューティクス， エルエルシー | 回旋筋腱板傷害を処置するためのｐｄｇｆ−生体マトリックス組成物および方法 |
| US8524265B2 (en) | 2006-08-17 | 2013-09-03 | Warsaw Orthopedic, Inc. | Medical implant sheets useful for tissue regeneration |
| AU2009291828C1 (en) | 2008-09-09 | 2016-03-17 | Biomimetic Therapeutics, Llc | Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries |
| US8609127B2 (en) | 2009-04-03 | 2013-12-17 | Warsaw Orthopedic, Inc. | Medical implant with bioactive material and method of making the medical implant |
| WO2010144696A1 (en) | 2009-06-11 | 2010-12-16 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
| JP6144049B2 (ja) | 2010-02-22 | 2017-06-07 | バイオミメティック セラピューティクス，リミテッド ライアビリティ カンパニー | 腱障害を処置するための血小板由来成長因子組成物及び方法 |
| US10034945B2 (en) | 2012-07-13 | 2018-07-31 | Trustees Of Tufts College | Silk powder compaction for production of constructs with high mechanical strength and stiffness |
| JP7025021B2 (ja) | 2015-10-26 | 2022-02-24 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 還元多糖および酸化多糖ならびにそれらの使用の方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2129820C (en) * | 1992-02-12 | 2003-06-17 | Helge Neidhardt | Dna sequences encoding novel growth/differentiation factors |
-
1995
- 1995-07-12 PT PT95928062T patent/PT770089E/pt unknown
- 1995-07-12 EP EP95928062A patent/EP0770089B1/en not_active Expired - Lifetime
- 1995-07-12 WO PCT/US1995/008745 patent/WO1996002559A1/en active IP Right Grant
- 1995-07-12 AT AT95928062T patent/ATE196147T1/de not_active IP Right Cessation
- 1995-07-12 DE DE69518760T patent/DE69518760T2/de not_active Expired - Fee Related
- 1995-07-12 CA CA002195246A patent/CA2195246A1/en not_active Abandoned
- 1995-07-12 US US08/765,662 patent/US5929213A/en not_active Expired - Fee Related
- 1995-07-12 ES ES95928062T patent/ES2151607T3/es not_active Expired - Lifetime
- 1995-07-12 DK DK95928062T patent/DK0770089T3/da active
- 1995-07-12 JP JP7523725A patent/JPH10503362A/ja active Pending
-
2000
- 2000-11-07 GR GR20000402461T patent/GR3034772T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2151607T3 (es) | 2001-01-01 |
| DE69518760T2 (de) | 2001-05-23 |
| EP0770089B1 (en) | 2000-09-06 |
| EP0770089A4 (en) | 1997-06-18 |
| DK0770089T3 (da) | 2000-10-23 |
| PT770089E (pt) | 2001-02-28 |
| JPH10503362A (ja) | 1998-03-31 |
| CA2195246A1 (en) | 1996-02-01 |
| DE69518760D1 (de) | 2000-10-12 |
| EP0770089A1 (en) | 1997-05-02 |
| WO1996002559A1 (en) | 1996-02-01 |
| US5929213A (en) | 1999-07-27 |
| ATE196147T1 (de) | 2000-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3034772T3 (en) | Growth differentiation factor-12 | |
| EP0776337A4 (en) | GROWTH DIFFERENTIATION FACTOR-11 | |
| EP1333035A3 (en) | Growth differentiation factor-8 | |
| EP1475440A3 (en) | Growth differentiation factor-3 | |
| EP1559726A3 (en) | Growth differentiation factor-10 | |
| EP0528858A4 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| ZA964215B (en) | Fatty acid treatment | |
| UA27035C2 (uk) | Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму | |
| EP0825996A4 (en) | FACTOR-1 (FHF-1) HOMOLOGATED FIBROBLAST GROWTH FACTOR AND METHODS OF USE | |
| OA09116A (en) | Novel protein, sequences containing the gene therefore vectors, methods of preparation and use. | |
| EP0227619A3 (en) | New protein and its use | |
| AU579593B2 (en) | Novel peptides which are active on the central nervous system and have an action on the cholinergic system | |
| AU2174392A (en) | Adn sequences of the human papillomavirus type 42, and diagnostic application thereof | |
| GB9410639D0 (en) | Method of improving fertilization | |
| ZA878249B (en) | Method and therapeutic compositions for the treatment of bleeding disorders | |
| ATE291918T1 (de) | Kombinationstherapie zur behandlung von tumoren | |
| DE69102069T2 (de) | 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen. | |
| DE59410423D1 (de) | Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose | |
| EP0870036A4 (en) | MAMMALIAN SYNTHETIC ALPHA-N-ACETYLGLUCOSAMINIDASE AND GENE SEQUENCES ENCODING IT | |
| EP0490383A3 (en) | Peptides of the hiv-gag protein, their preparation and use | |
| ATE103979T1 (de) | Menschliches lymphotoxin. | |
| EP0317279A3 (en) | Peptides for use in the purification of factor viii | |
| EP0832109A4 (en) | FIBROPLAST GROWTH FACTOR APPROVED FACTOR-2 AND METHODS OF USE | |
| GB9422294D0 (en) | Peptides for anti-allergy treatment | |
| NZ510970A (en) | The polycythaemia rubra vera gene and the use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |